First Foundation Advisors’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

First Foundation Advisors’s Portfolio IPCI Stock Details IPCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,000	Closed	-$4K	–	373
2018 Q2	$4K	Hold	1,000	–	–	﹤0.01%	333
2018 Q1	$6K	Sell	1,000 -47,917	-98%	-$346K	﹤0.01%	321
2017 Q4	$391K	Sell	48,917 -10,578	-18%	-$96.1K	0.02%	244
2017 Q3	$589K	Buy	59,495 +11,318	+23%	+$161K	0.03%	188
2017 Q2	$1.01M	Buy	48,177 +20,718	+75%	+$434K	0.06%	159
2017 Q1	$686K	Buy	27,459 +17,369	+172%	+$448K	0.04%	178
2016 Q4	$287K	Hold	10,090	–	–	0.02%	256
2016 Q3	$212K	Buy	+10,090	New	+$181K	0.01%	273
2016 Q2	–	Sell	-9,860	Closed	-$202K	–	320
2016 Q1	$202K	Buy	9,860 +4,860	+97%	+$108K	0.01%	271
2015 Q4	$101K	Hold	5,000	–	–	0.01%	282
2015 Q3	$90K	Buy	+5,000	New	+$131K	0.01%	229

Other funds holding IPCI

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

FANJ

Financial Architects (New Jersey) Marlton, New Jersey $663M AUM 15.53% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

First Foundation Advisors's IPCI Position: Q3 2018 in Review

First Foundation Advisors sold out of Intellipharmaceuticals International Inc. (IPCI) in Q3 2018, closing a stake of 1,000 shares — an estimated $4K sold.

First Foundation Advisors first reported a position in IPCI in Q3 2015 and held it in 11 quarters. The position peaked at $1.01M in Q2 2017. 10 funds tracked by Wall St. Rank hold IPCI as of Q3 2018.

First Foundation Advisors reported no remaining Intellipharmaceuticals International Inc. position as of Q3 2018 after selling out during the quarter.
First Foundation Advisors sold 1,000 Intellipharmaceuticals International Inc. shares in Q3 2018, an estimated $4K.
First Foundation Advisors first reported a position in Intellipharmaceuticals International Inc. in Q3 2015 and held it in 11 quarters.
First Foundation Advisors's Intellipharmaceuticals International Inc. position peaked at $1.01M in Q2 2017.
10 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q3 2018.

Based on First Foundation Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.